First Time Loading...
I

Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049

Watchlist Manager
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
Watchlist
Price: 51 CNY -0.43%
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one Inner Mongolia Furui Medical Science Co Ltd stock under the Base Case scenario is 28.5 CNY. Compared to the current market price of 51 CNY, Inner Mongolia Furui Medical Science Co Ltd is Overvalued by 44%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
28.5 CNY
Overvaluation 44%
Relative Value
Price
I
Worst Case
Base Case
Best Case

Valuation Multiples

12.9
P/S
P/S
Price to Sales
12.9
vs History
0
vs Industry
13
Median 3Y
5.1
Median 5Y
3.7
Industry
2.4
Forward
10.7
More Details
131.2
P/E
P/E
Price to Earnings
131.2
vs History
9
vs Industry
2
Median 3Y
53.1
Median 5Y
56.2
Industry
22.9
Forward
104.3
More Details
60.2
P/OCF
P/OCF
Price to OCF
60.2
vs History
0
vs Industry
6
Median 3Y
27.1
Median 5Y
17.4
Industry
17.1
More Details
221.7
P/FCFE
P/FCFE
Price to FCFE
221.7
vs History
0
vs Industry
3
Median 3Y
70.6
Median 5Y
39.6
Industry
23.2
More Details
8.6
P/B
P/B
Price to Book Value
8.6
vs History
0
vs Industry
7
Median 3Y
3.3
Median 5Y
2.3
Industry
2.1
More Details
12.3
EV/S
EV/S
Enterprise Value to Sales
12.3
vs History
0
vs Industry
12
Median 3Y
4.5
Median 5Y
3.3
Industry
2.6
Forward
10.2
More Details
16.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
16.6
vs History
0
vs Industry
11
Median 3Y
6.3
Median 5Y
4.8
Industry
5.1
More Details
59.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
59.3
vs History
0
vs Industry
5
Median 3Y
25.3
Median 5Y
20
Industry
13.6
Forward
34.4
More Details
59.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
59.3
vs History
0
vs Industry
6
Median 3Y
25.3
Median 5Y
20
Industry
17
Forward
165.7
More Details
57.4
EV/OCF
EV/OCF
Enterprise Value to OCF
57.4
vs History
0
vs Industry
7
Median 3Y
24.3
Median 5Y
15
Industry
15.8
More Details
117.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
117.7
vs History
1
vs Industry
4
Median 3Y
47.1
Median 5Y
31.4
Industry
17.6
More Details
6.9
EV/IC
EV/IC
Enterprise Value to IC
6.9
vs History
0
vs Industry
14
Median 3Y
2.5
Median 5Y
1.6
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Inner Mongolia Furui Medical Science Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
13.4B CNY 12.9 131.2 59.3 59.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
717.6B USD 21 136.9 61.8 71
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.8 46.5 34 37.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
360.9B USD 4.4 8.9 11.9 15.7
US
Merck & Co Inc
NYSE:MRK
324.7B USD 5.3 140.8 33.5 53.1
UK
AstraZeneca PLC
LSE:AZN
188.4B GBP 5.2 39.7 140.8 225.8
CH
Novartis AG
SIX:NOVN
181.7B CHF 4.3 13.4 9.8 16.3
CH
Roche Holding AG
SIX:ROG
170.7B CHF 2.9 14.8 8.5 10.1
US
Pfizer Inc
NYSE:PFE
156.4B USD 2.7 73.8 11 16.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.